Propofol attenuates angiotensin II-induced apoptosis in human coronary artery endothelial cells

British Journal of Anaesthesia

Volumn 107, Issue 4, 2011, Pages 525-532

  Chen, J ^a   Chen, W ^a   Zhu, M ^a   Zhu, Y ^a   Yin, H ^a   Tan, Z ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Anaesthetics i.v.; angiotensin II; apoptosis; endothelial cell; propofol; reactive oxygen species

Indexed keywords

ANGIOTENSIN II; C IAP 1 PROTEIN; CASPASE 3; CELL MARKER; CYTOCHROME C; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROPOFOL; PROTEIN BCL 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CORONARY ARTERY; DNA DETERMINATION; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; NICK END LABELING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

EID: 80052624365     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer197     Document Type: Article

References (32)

1. Colson P, Ryckwaert F, Coriat P. Renin angiotensin system antagonists and anesthesia. Anesth Analg 1999; 89: 1143-55 (Pubitemid 29521929)
2. Sata M, Fukuda D. Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis. J Med Invest 2010; 57: 12-25
3. Palomeque J, Delbridge L, Petroff MV. Angiotensin II: a regulator of cardiomyocyte function and survival. Front Biosci 2009; 14: 5118-33
4. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 1990; 259: 610-8
5. Mehta PK, Griendling KK. Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007; 292: 82-97
6. Li D, Tomson K, Yang B, Mehta P, Croker BP, Mehta JL. Modulation of constitutive nitric oxide synthase, bcl-2 and Fas expression in cultured human coronary endothelial cells exposed to anoxia-reoxygenation and angiotensin II: role of AT1 receptor activation. Cardiovasc Res 1999; 41: 109-15 (Pubitemid 29016050)
7. Dimmeler S, Rippmann V, Weiland U, Haendeler J, Zeiher AM. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res 1997; 81: 970-6
8. Alvarez E, Rodiño-Janeiro BK, Ucieda-Somoza R, González- Juanatey JR. Pravastatin counteracts angiotensin II-induced upregulationandactivation ofNADPHoxidaseat plasmamembrane of human endothelial cells. J Cardiovasc Pharmacol 2010; 55: 203-12
9. Rueckschloss U, Quinn MT, Holtz J, Morawietz H. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1. receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2002; 22: 1845-51 (Pubitemid 35315771)
10. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840-4
11. Guo JP, Panday MM, Consigny PM, Lefer AM. Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. Am J Physiol 1995; 269: H1122-31
12. Schulz R, Kelm M, Heusch G. Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 2004; 61: 402-13 (Pubitemid 38210147)
13. Loot AE, Schreiber JG, Fisslthaler B, Fleming I. Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase. J Exp Med 2009; 206: 2889-96
14. Rigby-Jones AE, Nolan JA, Priston MJ, Wright PM, Sneyd JR, Wolf AR. Pharmacokinetics of propofol infusions in critically ill neonates, infants, and children in an intensive care unit. Anesthesiology 2002; 97: 1393-400 (Pubitemid 35417436)
15. McDermott BJ, McWilliams S, Smyth K, et al. Protection of cardiomyocyte function by propofol during simulated ischemia is associated with a direct action to reduce pro-oxidant activity. J Mol Cell Cardiol 2007; 42: 600-8 (Pubitemid 46350879)
16. Aarts L, van der Hee R, Dekker I, de Jong J, Langemeijer H, Bast A. The widely used anesthetic agent propofol can replace alphatocopherol as an antioxidant. FEBS Lett 1995; 357: 83-5
17. Chen J, Gu Y, Shao Z, Luo J, Tan Z. Propofol protects against hydrogen peroxide-induced oxidative stress and cell dysfunction in human umbilical vein endothelial cells. Mol Cell Biochem 2010; 339: 43-54
18. Luo T, Xia Z, Ansley DM, et al. Propofol dose-dependently reduces tumor necrosis factor-alpha-induced human umbilical vein endothelial cell apoptosis: effects on Bcl-2 and Bax expression and nitric oxide generation. Anesth Analg 2005; 100: 1653-9 (Pubitemid 40712717)
19. Balyasnikova IV, Visintine DJ, Gunnerson HB, et al. Propofol attenuates lung endothelial injury induced by ischemia-reperfusion and oxidative stress. Anesth Analg 2005; 100: 929-36 (Pubitemid 40404190)
20. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-8 (Pubitemid 24176909)
21. Mehta JL, Hu B, Chen J, Li D. Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation. Arterioscler Thromb Vasc Biol 2003; 23: 2203-8 (Pubitemid 37532321)
22. Wakeling HG, Zimmerman JB, Howell S, Glass PS. Targeting effect compartment or central compartment concentration of propofol: what predicts loss of consciousness? Anesthesiology 1999; 90: 92-7
23. Casati A, Fanelli G, Casaletti E, Cedrati V, Veglia F, Torri G. The target plasma concentration of propofol required to place laryngeal mask versus cuffed oropharyngeal airway. Anesth Analg 1999; 88: 917-20 (Pubitemid 29168871)
24. Huang PL. Endothelial nitric oxide synthase and endothelial dysfunction. Curr Hypertens Rep 2003; 5: 473-80 (Pubitemid 38898972)
25. Chatterjee A, Black SM, Catravas JD. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vascul Pharmacol 2008; 49: 134-40
26. Fleming I, Busse R. Signal transduction of eNOS activation. Cardiovasc Res 1999; 43: 532-41 (Pubitemid 29369252)
27. Galley HF, Le Cras AE, Yassen K, Grant IS, Webster NR. Circulating tetrahydrobiopterin concentrations in patients with septic shock. Br J Anaesth 2001; 86: 578-80 (Pubitemid 32266325)
28. Singh U, Devaraj S, Vasquez-Vivar J, Jialal I. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J Mol Cell Cardiol 2007; 43: 780-91 (Pubitemid 350166380)
29. Dumitrescu C, Biondi R, Xia Y, et al. Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc Natl Acad Sci USA 2007; 104: 15081-6 (Pubitemid 47619596)
30. Lee YH, Mungunsukh O, Tutino RL, Marquez AP, Day RM. Angiotensin-II- induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells. J Cell Sci 2010; 123: 1634-43
31. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis 2007; 12: 913-22 (Pubitemid 46653300)
32. Wang B, Luo T, Chen D, Ansley DM. Propofol reduces apoptosis and up-regulates endothelial nitric oxide synthase protein expression in hydrogen peroxide-stimulated human umbilical vein endothelial cells. Anesth Analg 2007; 105: 1027-33 (Pubitemid 47479317)